Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use.

Nicole M Grogan Fleege,Yajing Li,Kelley M Kidwell, N Lynn Henry

Clinical breast cancer（2023）

Cited 0|Views10

No score

Abstract

This "real world" cohort demonstrates that estradiol concentrations above the postmenopausal range of the assay are frequently detected, including more than 1 year after the start of OFS. Additional research is needed to establish estradiol monitoring guidelines and optimal degree of ovarian suppression.

Translated text

Key words

Adjuvant endocrine therapy,Breast cancer,Clinical research,Estrogen-receptor-positive breast cancer,Ovarian function suppression

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined